The table below shows BIO-TECHNE Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$287.56M
$298.98M
$254.39M
$325.27M
$352.16M
$205.22M
Capital expenditure
$31.01M
$62.88M
$38.24M
$44.91M
$44.30M
$51.74M
Investing cash flow
-$35.18M
-$203.03M
-$265.65M
-$96.85M
-$243.52M
$27.09M
Dividends paid
$50.39M
$50.42M
$50.28M
$50.19M
$49.62M
TECH operating cash flow (10-K history)
BIO-TECHNE Corp reported operating cash flow of $287.56M for fiscal year 2025. That is down 3.8% from $298.98M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $144.16M (FY 2016) to $287.56M. Figures come from the company's audited annual reports as filed with the SEC.
